Your browser doesn't support javascript.
loading
Development of a Clinical Decision Support System for Severity Risk Prediction and Triage of COVID-19 Patients at Hospital Admission: an International Multicenter Study
Guangyao Wu; Pei Yang; Henry C. Woodruff; Xiangang Rao; Julien Guiot; Anne-Noelle Frix; Michel Moutschen; Renaud Louis; Jiawei Li; Jing Li; Chenggong Yan; Dan Du; Shengchao Zhao; Yi Ding; Bin Liu; Wenwu Sun; Fabrizio Albarello; Vincenzo Schinina; Emanuele Nicastri; Mariaelena Occhipinti; Giovanni Barisione; Emanuela Barisione; Iva Halilaj; Yuanliang Xie; Xiang Wang; Pierre Lovinfosse; Jianlin Wu; Philippe Lambin.
Affiliation
  • Guangyao Wu; Maastricht university
  • Pei Yang; The Central Hospital of Wuhan
  • Henry C. Woodruff; Maastricht University
  • Xiangang Rao; The Central Hospital of Huangshi
  • Julien Guiot; CHU of Liege
  • Anne-Noelle Frix; CHU of Liege
  • Michel Moutschen; CHU of Liege
  • Renaud Louis; CHU of Liege
  • Jiawei Li; China Resources Wuhan Iron and Steel Hospital
  • Jing Li; The Central Hospital of Shaoyang
  • Chenggong Yan; Maastricht University
  • Dan Du; The Central Hospital of Wuhan
  • Shengchao Zhao; The Central Hospital of Wuhan
  • Yi Ding; The Central Hospital of Wuhan
  • Bin Liu; The Central Hospital of Wuhan
  • Wenwu Sun; The Central Hospital of Wuhan
  • Fabrizio Albarello; IRCCS, Lazzaro Spallanzani, Via Portuense
  • Vincenzo Schinina; IRCCS, Lazzaro Spallanzani, Via Portuense
  • Emanuele Nicastri; IRCCS, Lazzaro Spallanzani, Via Portuense
  • Mariaelena Occhipinti; Clinical and Experimental Sciences "Mario Serio", University of Florence
  • Giovanni Barisione; IRCCS Ospedale Policlinico San Martino
  • Emanuela Barisione; IRCCS Ospedale Policlinico San Martino
  • Iva Halilaj; Maastricht University
  • Yuanliang Xie; The Central Hospital of Wuhan
  • Xiang Wang; The Central Hospital of Wuhan
  • Pierre Lovinfosse; CHU of Liege
  • Jianlin Wu; Affiliated Zhongshan Hospital of Dalian University
  • Philippe Lambin; Maastricht University
Preprint in English | medRxiv | ID: ppmedrxiv-20053413
ABSTRACT
Key pointsO_ST_ABSQuestionC_ST_ABSHow do nomograms and machine-learning algorithms of severity risk prediction and triage of COVID-19 patients at hospital admission perform? FindingsThis model was prospectively validated on six test datasets comprising of 426 patients and yielded AUCs ranging from 0.816 to 0.976, accuracies ranging from 70.8% to 93.8%, sensitivities ranging from 83.7% to 100%, and specificities ranging from 41.0% to 95.7%. The cut-off probability values for low, medium, and high-risk groups were 0.072 and 0.244. MeaningThe findings of this study suggest that our models performs well for the diagnosis and prediction of progression to severe or critical illness of COVID-19 patients and could be used for triage of COVID-19 patients at hospital admission. IMPORTANCEThe outbreak of the coronavirus disease 2019 (COVID-19) has globally strained medical resources and caused significant mortality for severely and critically ill patients. However, the availability of validated nomograms and the machine-learning model to predict severity risk and triage of affected patients is limited. OBJECTIVETo develop and validate nomograms and machine-learning models for severity risk assessment and triage for COVID-19 patients at hospital admission. DESIGN, SETTING, AND PARTICIPANTSA retrospective cohort of 299 consecutively hospitalized COVID-19 patients at The Central Hospital of Wuhan, China, from December 23, 2019, to February 13, 2020, was used to train and validate the models. Six cohorts with 426 patients from eight centers in China, Italy, and Belgium, from February 20, 2020, to March 21, 2020, were used to prospectively validate the models. MAIN OUTCOME AND MEASURESThe main outcome was the onset of severe or critical illness during hospitalization. Model performances were quantified using the area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, and specificity. RESULTSOf the 299 hospitalized COVID-19 patients in the retrospective cohort, the median age was 50 years ((interquartile range, 35.5-63.0; range, 20-94 years) and 137 (45.8%) were men. Of the 426 hospitalized COVID-19 patients in the prospective cohorts, the median age was 62.0 years ((interquartile range, 50.0-72.0; range, 19-94 years) and 236 (55.4%) were men. The model was prospectively validated on six cohorts yielding AUCs ranging from 0.816 to 0.976, with accuracies ranging from 70.8% to 93.8%, sensitivities ranging from 83.7% to 100%, and specificities ranging from 41.0% to 95.7%. The cut-off values of the low, medium, and high-risk probabilities were 0.072 and 0.244. The developed online calculators can be found at https//covid19risk.ai/. CONCLUSION AND RELEVANCEThe machine learning models, nomograms, and online calculators might be useful for the prediction of onset of severe and critical illness among COVID-19 patients and triage at hospital admission. Further prospective research and clinical feedback are necessary to evaluate the clinical usefulness of this model and to determine whether these models can help optimize medical resources and reduce mortality rates compared with current clinical practices.
License
cc_no
Full text: Available Collection: Preprints Database: medRxiv Type of study: Cohort_studies / Diagnostic study / Experimental_studies / Observational study / Prognostic study / Rct Language: English Year: 2020 Document type: Preprint
Full text: Available Collection: Preprints Database: medRxiv Type of study: Cohort_studies / Diagnostic study / Experimental_studies / Observational study / Prognostic study / Rct Language: English Year: 2020 Document type: Preprint
...